Yuki Koga, a pharmacist at Hiroshima University Hospital in Japan, has a message for the millions of people living with food allergies: your test results might not be telling you the whole story.
Current allergy tests can detect whether someone has IgE antibodies—immune proteins that cause allergic reactions—but they cannot tell doctors whether those antibodies will actually make a person sick. This means some people are told to avoid foods they could safely eat, while others discover their allergy is worse than any test suggested.
"Conventional tests may classify individuals as having food allergies when allergen-specific IgE is present but does not lead to actual symptom development," Koga explained. "This discrepancy between test results and clinical symptoms represents a major challenge, contributing to diagnostic uncertainty and unnecessary dietary restrictions."
Now, Koga and a team from three Japanese institutions—Hiroshima University, Aichi Children's Health and Medical Center, and Shimane University—have developed an upgraded allergy test that finally closes this gap. Their method, called the modified AlphaCL test, can identify not just whether IgE antibodies are present, but whether those antibodies are actually capable of triggering a reaction.
The secret lies in how allergies work at the cellular level. For an allergic reaction to occur, allergens must bind to multiple IgE antibodies sitting on the surface of immune cells called mast cells. This binding, called cross-linking, is what flips the switch that causes symptoms like hives, swelling, or breathing trouble.
Traditional tests ignore this step entirely. The modified AlphaCL test mimics it using modified allergens and a streamlined process that does not require living cells. By washing away interfering proteins from blood samples, the test can measure how much "functionally active" IgE—a person's antibodies that are actually capable of causing symptoms—a patient has.
The research, published in the journal Methods, builds on an earlier version of the AlphaCL test, which was originally created to study hive reactions. The upgraded version overcomes a major limitation: earlier methods struggled with interference from other blood components, making results less reliable.
Oral food challenges, where patients eat increasing amounts of a suspected allergen under medical supervision, remain the gold standard for diagnosis. But these tests carry real risk—severe reactions can occur. A simpler, safer tool that better predicts reaction risk has been a goal for allergists for years.
"This study demonstrates the feasibility of detecting functional, allergy-inducing IgE through a more practical and accessible approach," Koga said, calling the method "methodologically significant."
For patients and families navigating food allergies, more accurate testing could mean fewer anxious food challenges, less restrictive diets, and better information to guide life-changing decisions about what to eat and what to avoid.